A treatment for amyotrophic lateral sclerosis (ALS) has shown improvement in some patients, with reports of stabilized decline, improved strength, and mobility. The treatment, which has received FDA fast track designation, appears to have benefited a subset of patients, including those with a rare form of the disease. However, it is unclear if the treatment is universally effective, as different reports mention varying patient responses and specific types of ALS.